Loading, please wait....jpg)
.jpg)
CONTINUING PHARMACY EDUCATION
Thrombolytics for Acute Ischemic Stroke: Have We Found the Right (Tenecte)plase in Therapy?
Speaker: Karen Berger, PharmD, FASHP, FCCM, BCPS, BCCCP, Assistant Professor, Nova Southeastern University, Davie, FL
ACPE Universal Program ID# 0122-0000-23-024-H01-P
1 Contact Hours [0.1 CEU]
Release Date: February 13, 2023
Fee
$0.00
CE Hours
1.00
CE Units
0.100
Activity Type
- Knowledge
Target Audience(s)
- Pharmacists
Accreditation(s)
|
Premier, Inc. is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
|
Requirements for CE Credit
There are 2 steps to completing this home-study CE.
Step 1: Watch the video presentation in its entirety.
Step 2: Click on "Take the Test" to complete the post-test and evaluation.
Please Note: A handout is provided. Please print it out and follow along with the audio recording.
Objectives
- Describe the pharmacologic management of ischemic stroke
- Compare and contrast thrombolytics for the management of acute ischemic stroke
- Discuss recent articles and the potential place in therapy of tenecteplase for acute ischemic stroke
- Discuss key challenges in the implementation of tenecteplase for stroke management
Speaker(s)/Author(s)
|
Karen Berger, PharmD, FCCM, BCPS, BCCCP
|
Activity Number
0122-0000-23-024-H01-P
Release Date:
Feb 13, 2023
Credit Expiration Date:
Feb 13, 2026
CE Hours
1.00